Stock Update: Merck & Co Inc (NYSE:MRK) – Merck, Bristol heat up immunotherapy race in lung cancer

[Reuters – UK Focus] – Bristol-Myers Squibb and Merck & Co broke further away from rival drugmakers in the race to treat lung cancer with a new generation of immune system therapies, adding . . . → Read More: Stock Update: Merck & Co Inc (NYSE:MRK) – Merck, Bristol heat up immunotherapy race in lung cancer Similar Articles: Company Update: Bristol-Myers Squibb Company (NYSE:BMY) – Merck, Bristol heat up immunotherapy race in lung cancer Market Update: Merck & Co Inc (NYSE:MRK) – Merck says animal food additive Zilmax seen safe in review Stock Update (NYSE:MRK): U.S. FDA approves Merck insomnia drug
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.